Specific Protein Linked to Development of Asthma Paves Way for New Therapy

Scientists have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent its development in young children.

Asthma is a chronic disease of the airways that affects more than 300 million people worldwide. It is the number one illness leading to school absences in children, and accounts for more than 1.8 million emergency room visits annually. There is no cure; all current therapies focus on providing symptomatic relief and reducing the number and severity of attacks.

Preventing Development of Asthma With Psychedelic Drug
A psychedelic drug, (R)-DOI, may help prevent asthma development. Research led by Charles Nicholas has found that this drug prevents the development of allergic asthma in a mouse model.

Lead researcher Mitchell H. Grayson said that understanding the molecular mechanisms by which asthma develops and establishes itself as a chronic disease is key to elucidating alternative and potentially curative therapies.

The researchers previously found evidence linking a human chemokine (protein) called CCL28 to the development of chronic asthma. However, this study is the first that examines structural analysis and its impact on disease development.

Lead researcher Brian F. Volkman said that they found that even in the absence of a viral infection, CCL28 can play a role in the induction of asthma pathology, when the protein is natively folded. If unfolded, it does not.

Millions in Britain Who are Receiving Asthma Treatment may Have Been Wrongly Diagnosed
The National Institute for Health and Care Excellence (NICE) has found that more than 1 million people in Britain who are receiving treatment for asthma may have been wrongly diagnosed.

Volkman continued that they propose that by exploiting the unique structural features of CCL28, potent and specific CCL28 inhibitors may be developed. This work is the first step in generating a novel type of asthma therapy that may have the power to prevent development of post-viral asthma in young children.

The findings are published in the Journal of Biological Chemistry.

The Changing Face of Pediatric Asthma
It is a long-standing belief that city dwellers suffer disproportionately from asthma.

Source-ANI

Allergic Asthma Response-Triggering Cellular Pathway Identified
A novel signalling pathway critical to the immune response of cells associated with the initiation of allergic asthma has been identified by researchers at the University of California.